Literature DB >> 25566744

Sleeve Gastrectomy Does Not Cause Hypertrophy and Reprogramming of Intestinal Glucose Metabolism in Rats.

Michael B Mumphrey1, Zheng Hao, R Leigh Townsend, Laurel M Patterson, Hans-Rudolf Berthoud.   

Abstract

BACKGROUND: Clinical studies have shown similar rapid improvements in body mass and glycemic control after Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG). Evidence suggests that adaptive intestinal tissue growth and reprogramming of intestinal glucose disposal play a key role in the beneficial effects on glucose homeostasis after RYGB, but it is not known whether such adaptive changes also occur after sleeve gastrectomy.
METHODS: High-fat diet-induced obese rats were subjected to either VSG or RYGB, and intestinal growth and functional adaptations were assessed by using morphometric, immunohistochemical, and immuno-blot techniques, 3 months after surgery or sham surgery.
RESULTS: The cross-sectional areas of the Roux and common limbs are significantly increased after RYGB compared with sham surgery (Roux limb: 17.1 ± 4.0 vs. 5.5 ± 0.1 mm(2); common limb: 11.7 ± 0.6 vs. 5.1 ± 0.5 mm(2); p < 0.01), but the cross-sectional area of the corresponding jejunum is not different from controls after VSG. Similarly, mucosal thickness and the number of GLP-1 cells are not increased after VSG. Protein expression of hexokinase II is increased fourfold (p < 0.01) in the Roux limb after RYGB, but not in the jejunum after VSG.
CONCLUSIONS: Adaptive hypertrophy and reprogramming of glucose metabolism in the small intestine are not necessary for VSG to improve body composition and glycemic control. The similar beneficial effects of VSG and RYGB on glucose homeostasis might be mediated by different mechanisms.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25566744      PMCID: PMC4496328          DOI: 10.1007/s11695-014-1547-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  21 in total

1.  Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.

Authors:  Fabiola Romero; Joana Nicolau; Lílliam Flores; Roser Casamitjana; Ainitze Ibarzabal; Antonio Lacy; Josep Vidal
Journal:  Surg Endosc       Date:  2012-08       Impact factor: 4.584

2.  Quantitative body composition analysis in awake mice and rats by magnetic resonance relaxometry.

Authors:  Basil Künnecke; Philippe Verry; Agnès Bénardeau; Markus von Kienlin
Journal:  Obes Res       Date:  2004-10

3.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

4.  Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.

Authors:  D L Sigalet; O Bawazir; G R Martin; L E Wallace; G Zaharko; A Miller; A Zubaidi
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

5.  Comparison of short-term outcome of laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: A prospective randomized controlled multicenter SLEEVEPASS study with 6-month follow-up.

Authors:  M Helmiö; M Victorzon; J Ovaska; M Leivonen; A Juuti; P Peromaa-Haavisto; P Nuutila; T Vahlberg; P Salminen
Journal:  Scand J Surg       Date:  2014-02-12       Impact factor: 2.360

6.  Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats.

Authors:  M B Mumphrey; L M Patterson; H Zheng; H-R Berthoud
Journal:  Neurogastroenterol Motil       Date:  2012-10-24       Impact factor: 3.598

7.  Role of glucagon-like peptide-2 deficiency in neonatal short-bowel syndrome using neonatal piglets.

Authors:  Zheng Hua; Justine M Turner; David L Sigalet; Pamela R Wizzard; Patrick N Nation; Diana R Mager; Ron O Ball; Paul B Pencharz; Paul W Wales
Journal:  Pediatr Res       Date:  2013-03-12       Impact factor: 3.756

8.  Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.

Authors:  Gary R Martin; Laurie E Wallace; David L Sigalet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-02-12       Impact factor: 4.052

9.  Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.

Authors:  Tatsuru Kaji; Hiroaki Tanaka; Heather Redstone; Laurie E Wallace; Jens J Holst; David L Sigalet
Journal:  J Surg Res       Date:  2008-06-02       Impact factor: 2.192

10.  Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats.

Authors:  Carl Frederik Hansen; Marco Bueter; Nadine Theis; Thomas Lutz; Sarah Paulsen; Louise S Dalbøge; Niels Vrang; Jacob Jelsing
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more
  15 in total

Review 1.  The Role of GLP-1 in the Metabolic Success of Bariatric Surgery.

Authors:  Chelsea R Hutch; Darleen Sandoval
Journal:  Endocrinology       Date:  2017-12-01       Impact factor: 4.736

2.  Upregulation of Intestinal NLRP6 Inflammasomes After Roux-en-Y Gastric Bypass Promotes Gut Immune Homeostasis.

Authors:  Geng Wang; Qingbo Wang; Jie Bai; Ning Zhao; Yu Wang; Rui Zhou; Wen Kong; Tianshu Zeng; Kaixiong Tao; Guobin Wang; Zefeng Xia
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

3.  Vertical sleeve gastrectomy induces enteroendocrine cell differentiation of intestinal stem cells through bile acid signaling.

Authors:  Ki-Suk Kim; Bailey Ce Peck; Yu-Han Hung; Kieran Koch-Laskowski; Landon Wood; Priya H Dedhia; Jason R Spence; Randy J Seeley; Praveen Sethupathy; Darleen A Sandoval
Journal:  JCI Insight       Date:  2022-06-08

4.  Additional effects of duodenojejunal bypass on glucose metabolism in a rat model of sleeve gastrectomy.

Authors:  Hiroomi Takayama; Masayuki Ohta; Kazuhiro Tada; Kiminori Watanabe; Takahide Kawasaki; Yuichi Endo; Yukio Iwashita; Masafumi Inomata
Journal:  Surg Today       Date:  2019-01-31       Impact factor: 2.549

Review 5.  Glucagon-Like Peptide-1: Actions and Influence on Pancreatic Hormone Function.

Authors:  Ellen M Davis; Darleen A Sandoval
Journal:  Compr Physiol       Date:  2020-03-12       Impact factor: 8.915

Review 6.  Gastrointestinal peptides in eating-related disorders.

Authors:  Kimberly R Smith; Timothy H Moran
Journal:  Physiol Behav       Date:  2021-05-11

Review 7.  Mechanisms for the metabolic success of bariatric surgery.

Authors:  Darleen A Sandoval
Journal:  J Neuroendocrinol       Date:  2019-04-10       Impact factor: 3.870

8.  Deregulation of transcription factors controlling intestinal epithelial cell differentiation; a predisposing factor for reduced enteroendocrine cell number in morbidly obese individuals.

Authors:  Bettina K Wölnerhanssen; Andrew W Moran; Galina Burdyga; Anne Christin Meyer-Gerspach; Ralph Peterli; Michael Manz; Miriam Thumshirn; Kristian Daly; Christoph Beglinger; Soraya P Shirazi-Beechey
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

9.  The endogenous preproglucagon system is not essential for gut growth homeostasis in mice.

Authors:  Pernille Wismann; Pernille Barkholt; Thomas Secher; Niels Vrang; Henrik B Hansen; Palle Bekker Jeppesen; Laurie L Baggio; Jacqueline A Koehler; Daniel J Drucker; Darleen A Sandoval; Jacob Jelsing
Journal:  Mol Metab       Date:  2017-04-27       Impact factor: 7.422

Review 10.  Physiological and molecular responses to bariatric surgery: markers or mechanisms underlying T2DM resolution?

Authors:  Chelsea R Hutch; Darleen A Sandoval
Journal:  Ann N Y Acad Sci       Date:  2016-09-26       Impact factor: 6.499

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.